Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases.
J Pers Med. 2022 Jun 21;12(7):1021. doi: 10.3390/jpm12071021.
J Pers Med. 2022.
PMID: 35887517
Free PMC article.
Review.
Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models.
Feijóo-Bandín S, Aragón-Herrera A, Otero-Santiago M, Anido-Varela L, Moraña-Fernández S, Tarazón E, Roselló-Lletí E, Portolés M, Gualillo O, González-Juanatey JR, Lago F.
Feijóo-Bandín S, et al.
Int J Mol Sci. 2022 May 18;23(10):5634. doi: 10.3390/ijms23105634.
Int J Mol Sci. 2022.
PMID: 35628443
Free PMC article.
Review.
Sodium-glucose co-transporter 2 inhibitors, also known as gliflozins, were developed as a novel class of anti-diabetic agents that promote glycosuria through the prevention of glucose reabsorption in the proximal tubule by sodium-glucose co-transporter 2. ...
Sodium-glucose co-transporter 2 inhibitors, also known as gliflozins, were developed as a novel class of anti-diabetic agents that pr …
Item in Clipboard
Cite
Cite